New drug can track down MRSA to the farthest reaches.
A researcher from UMC Utrecht has successfully developed a proof-of-concept drug capable of killing the intracellular components of Methicillin-resistant staphylococcus aureus (MRSA). These components allow for persistence to antibiotics and play a huge part in the high mortality rates associated wi...
| Publicado no: | Research'eu results magazine November, 67 (2017). |
|---|---|
| Formato: | Artigo |
| Idioma: | English |